Pluristem’s post nuclear exposure study in primates a success
Pluristem Therapeutics announced the promising results of its non-human primates (NHP) pilot study for PLX-R18 as a treatment for Acute Radiation Syndrome (ARS).
List view / Grid view
Pluristem Therapeutics announced the promising results of its non-human primates (NHP) pilot study for PLX-R18 as a treatment for Acute Radiation Syndrome (ARS).
The collaboration focuses on the delivery of an educational programme consisting of a suite of flexible Master’s level professional courses including short ones and a full Master’s programme.
Kidney cancer rates have increased by 40% over the last 10 years in the UK, and the rise is expected to continue. An estimated 20,000 kidney cancer cases have been caused by obesity over the last decade in England, according to new figures from Cancer Research UK.
The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, has today announced the launch of the Chemical Safety Library (CSL) Service, which allows hazardous reaction information to be captured, stored and shared, to improve laboratory safety.
The designation certifies that Exco InTouch’s practices meet or exceed the data privacy and security principles outlined by US Department of Commerce and European Commission.
25 July 2016 | By Niamh Louise Marriott, Digital Content Producer
Prokarium announced the award of funding from the UK governments for the development of three new vaccines against Zika, bacterial diarrhoea and plague...